May 8, 2018 / 9:50 PM / 5 months ago

BRIEF-Anaptysbio Qtrly Loss Per Share $0.63

May 8 (Reuters) - AnaptysBio Inc:

* ANAPTYSBIO ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES PIPELINE UPDATES

* ANAPTYSBIO INC - TOP-LINE PHASE 2A DATA FROM ANB020 IN EOSINOPHILIC ASTHMA EXPECTED IN Q3 OF 2018

* ANAPTYSBIO INC - EXPECTS THAT ITS CASH, CASH EQUIVALENTS AND INVESTMENTS WILL FUND ITS CURRENT OPERATING PLAN THROUGH END OF 2019

* ANAPTYSBIO INC QTRLY LOSS PER SHARE $0.63 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below